He also did recognize the effect of current budget cuts are having on the progression of R and D, as anyone who applies for and receives grants these days knows the bar has been raised and it is a bit more difficult to secure them, as a result many are looking to investors outside the NIH for funding...
Posted to
The Medical Quack .... by Barbara Duck
on 09-24-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, Genomics, healthcare, Biotech, Grants, Budgets, R and D, NIH, National Institue of Health
Many of the generic manufacturers started years back with knock off drugs to sell locally in India, but now the game is changing to where US Pharma is using some of the talent, which costs less than R and D individuals here in the states, to further develop existing work, in other words somewhat continue...
Posted to
The Medical Quack .... by Barbara Duck
on 09-05-2008
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Biotech, Cancer, FDA, Budgets, R and D, Alzheimers, Outsourcing
Personalized Medicine and Genomics are getting some serious attention, why, because it will save money and hopefully better healthcare in the process. The days when your DNA will determine what drug your physician will prescribe may not be too far off. Developers and researchers are...